Literature DB >> 30895610

Extrasynaptic γ-aminobutyric acid type A receptor-mediated sex differences in the antiseizure activity of neurosteroids in status epilepticus and complex partial seizures.

Doodipala Samba Reddy1, Chase Matthew Carver2, Bryan Clossen1, Xin Wu1.   

Abstract

OBJECTIVE: Sex differences are evident in the antiseizure activity of neurosteroids; however, the potential mechanisms remain unclear. In this study, we sought to determine whether differences in target extrasynaptic δ-subunit γ-aminobutyric acid type A (GABA-A) receptor expression and function underlie the sex differences in seizure susceptibility and the antiseizure activity of neurosteroids.
METHODS: Sex differences in seizure susceptibility and protective activity of three distinct neurosteroids-allopregnanolone (AP), androstanediol (AD), and ganaxolone-were evaluated in the pilocarpine model of status epilepticus (SE) and kindling seizure test in mice. Immunocytochemistry was used for δGABA-A receptor expression analysis, and patch-clamp recordings in brain slices evaluated its functional currents.
RESULTS: Sex differences were apparent in kindling epileptogenic seizures, with males exhibiting a faster progression to a fully kindled state. Neurosteroids AP, AD, or ganaxolone produced dose-dependent protection against SE and acute partial seizures. However, female mice exhibited strikingly enhanced sensitivity to the antiseizure activity of neurosteroids compared to males. Sex differences in neurosteroid protection were unrelated to pharmacokinetic factors, as plasma levels of neurosteroids associated with seizure protection were similar between sexes. Mice lacking extrasynaptic δGABA-A receptors did not exhibit sex differences in neurosteroid protection. Consistent with a greater abundance of extrasynaptic δGABA-A receptors, AP produced a significantly greater potentiation of tonic currents in dentate gyrus granule cells in females than males; however, such enhanced AP sensitivity was diminished in δGABA-A receptor knockout female mice. SIGNIFICANCE: Neurosteroids exhibit greater antiseizure potency in females than males, likely due to a greater abundance of extrasynaptic δGABA-A receptors that mediate neurosteroid-sensitive tonic currents and seizure protection. These findings indicate the potential to develop personalized gender-specific neurosteroid treatments for SE and epilepsy in men and women, including catamenial epilepsy. Wiley Periodicals, Inc.
© 2019 International League Against Epilepsy.

Entities:  

Keywords:  GABA-A receptor; epilepsy; kindling; neurosteroids; sex difference; tonic inhibition

Mesh:

Substances:

Year:  2019        PMID: 30895610      PMCID: PMC6447432          DOI: 10.1111/epi.14693

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  49 in total

1.  Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy.

Authors:  M E Barton; B D Klein; H H Wolf; H S White
Journal:  Epilepsy Res       Date:  2001-12       Impact factor: 3.045

Review 2.  Neurosteroids: expression of steroidogenic enzymes and regulation of steroid biosynthesis in the central nervous system.

Authors:  A G Mensah-Nyagan; J L Do-Rego; D Beaujean; V Luu-The; G Pelletier; H Vaudry
Journal:  Pharmacol Rev       Date:  1999-03       Impact factor: 25.468

3.  Profiling neurosteroids in cerebrospinal fluids and plasma by gas chromatography/electron capture negative chemical ionization mass spectrometry.

Authors:  Y S Kim; H Zhang; H Y Kim
Journal:  Anal Biochem       Date:  2000-01-15       Impact factor: 3.365

4.  Enhanced neurosteroid potentiation of ternary GABA(A) receptors containing the delta subunit.

Authors:  Kai M Wohlfarth; Matt T Bianchi; Robert L Macdonald
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

5.  Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice.

Authors:  R M Mihalek; P K Banerjee; E R Korpi; J J Quinlan; L L Firestone; Z P Mi; C Lagenaur; V Tretter; W Sieghart; S G Anagnostaras; J R Sage; M S Fanselow; A Guidotti; I Spigelman; Z Li; T M DeLorey; R W Olsen; G E Homanics
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

6.  The ovarian hormones and absence epilepsy: a long-term EEG study and pharmacological effects in a genetic absence epilepsy model.

Authors:  G van Luijtelaar; B Budziszewska; L Jaworska-Feil; J Ellis; A Coenen; W Lasoń
Journal:  Epilepsy Res       Date:  2001-09       Impact factor: 3.045

7.  Effects of neurosteroids on spike-wave discharges in the genetic epileptic WAG/Rij rat.

Authors:  B Budziszewska; G Van Luijtelaar; A M Coenen; M Leśkiewicz; W Lasoń
Journal:  Epilepsy Res       Date:  1999-01       Impact factor: 3.045

8.  Sex differences in GABA(A)ergic system in rat substantia nigra pars reticulata.

Authors:  Teresa Ravizza; Linda K Friedman; Solomon L Moshé; Jana Velísková
Journal:  Int J Dev Neurosci       Date:  2003-08       Impact factor: 2.457

9.  Effects of gender and gonadectomy on responses to chronic benzodiazepine receptor agonist exposure in rats.

Authors:  M A Wilson; R Biscardi
Journal:  Eur J Pharmacol       Date:  1992-04-29       Impact factor: 4.432

10.  The influence of subunit composition on the interaction of neurosteroids with GABA(A) receptors.

Authors:  Delia Belelli; Anna Casula; Alice Ling; Jeremy J Lambert
Journal:  Neuropharmacology       Date:  2002-09       Impact factor: 5.250

View more
  13 in total

1.  Isobolographic Analysis of Antiseizure Activity of the GABA Type A Receptor-Modulating Synthetic Neurosteroids Brexanolone and Ganaxolone with Tiagabine and Midazolam.

Authors:  Shu-Hui Chuang; Doodipala Samba Reddy
Journal:  J Pharmacol Exp Ther       Date:  2019-12-16       Impact factor: 4.030

Review 2.  Synthetic neuroactive steroids as new sedatives and anaesthetics: Back to the future.

Authors:  Francesca M Manzella; Douglas F Covey; Vesna Jevtovic-Todorovic; Slobodan M Todorovic
Journal:  J Neuroendocrinol       Date:  2022-01-10       Impact factor: 3.627

3.  Pharmacological inhibition of STriatal-Enriched protein tyrosine Phosphatase by TC-2153 reduces hippocampal excitability and seizure propensity.

Authors:  Jennifer M Walters; Eung Chang Kim; Jiaren Zhang; Han Gil Jeong; Archit Bajaj; Brian C Baculis; Gregory C Tracy; Baher Ibrahim; Catherine A Christian-Hinman; Daniel A Llano; Graham R Huesmann; Hee Jung Chung
Journal:  Epilepsia       Date:  2022-02-21       Impact factor: 6.740

4.  Effect of progesterone administration in male and female smokers on nicotine withdrawal and neural response to smoking cues: role of progesterone conversion to allopregnanolone.

Authors:  Andrew M Novick; Korrina A Duffy; Rachel L Johnson; Mary D Sammel; Wen Cao; Andrew A Strasser; Mehmet Sofuoglu; Alexandra Kuzma; James Loughead; A Leslie Morrow; C Neill Epperson
Journal:  Biol Sex Differ       Date:  2022-10-23       Impact factor: 8.811

Review 5.  Sex Differences in the Epilepsies and Associated Comorbidities: Implications for Use and Development of Pharmacotherapies.

Authors:  Catherine A Christian; Doodipala Samba Reddy; Jamie Maguire; Patrick A Forcelli
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

6.  Does Stress Trigger Seizures? Evidence from Experimental Models.

Authors:  Doodipala Samba Reddy; Wesley Thompson; Gianmarco Calderara
Journal:  Curr Top Behav Neurosci       Date:  2022

Review 7.  Neurosteroid replacement therapy for catamenial epilepsy, postpartum depression and neuroendocrine disorders in women.

Authors:  Doodipala Samba Reddy
Journal:  J Neuroendocrinol       Date:  2021-09-10       Impact factor: 3.870

8.  Comparative profile of refractory status epilepticus models following exposure of cholinergic agents pilocarpine, DFP, and soman.

Authors:  Doodipala Samba Reddy; Marcus Zaayman; Ramkumar Kuruba; Xin Wu
Journal:  Neuropharmacology       Date:  2021-04-18       Impact factor: 5.273

Review 9.  Molecular mechanisms of sex differences in epilepsy and seizure susceptibility in chemical, genetic and acquired epileptogenesis.

Authors:  Doodipala Samba Reddy; Wesley Thompson; Gianmarco Calderara
Journal:  Neurosci Lett       Date:  2021-02-18       Impact factor: 3.046

Review 10.  Allopregnanolone: An overview on its synthesis and effects.

Authors:  Silvia Diviccaro; Lucia Cioffi; Eva Falvo; Silvia Giatti; Roberto Cosimo Melcangi
Journal:  J Neuroendocrinol       Date:  2021-06-29       Impact factor: 3.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.